Role of striatal serotonin(2A) and serotonin(2C) receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

Journal of Neurochemistry

Volumn 74, Issue 2, 2000, Pages 693-701

  Lucas, Guillaume ^a   Spampinato, Umberto ^a  

^a CNRS   (France)

Author keywords

Dopamine; Freely moving rats; Microdialysis; Serotonin; Serotonin 5 HT(2A) receptors; Serotonin 5 HT(2C) receptors; Striatum

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; DOPAMINE; EPLIVANSERIN; HALOPERIDOL; RITANSERIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; INDOLE DERIVATIVE; ISOPROTEIN; PYRIDINE DERIVATIVE; SEROTONIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE UPTAKE; DRUG RECEPTOR BINDING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; EXTRACELLULAR SPACE; METABOLISM; SPRAGUE DAWLEY RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINES; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; EXTRACELLULAR SPACE; HALOPERIDOL; INDOLES; MALE; PROTEIN ISOFORMS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0033621576     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.740693.x     Document Type: Article

References (48)

1. 2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34, 1635-1645.
2. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci. 16, 105-110.
3. Benloucif S. and Galloway M. P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200, 1-8.
4. Benloucif S., Keegan M. J., and Galloway M. P. (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265, 373-377.
5. 3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum. Mol. Pharmacol. 54, 373-377.
6. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rats. Neuropharmacology 34, 269-279.
7. De Deurwaerdère P., Bonhomme N., Lucas G., Le Moal M., and Spampinato U. (1996) Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J. Neurochem. 66, 210-215.
8. 4 receptors indirectly enhances in vivo dopamine release in the rat striatum. J. Neurochem. 68, 195-203.
9. Deutch A. Y., Moghaddam B., Innis R. B., Krystal J. H., Aghajanian G. K., Bunney B. S., and Charney D. S. (1991) Mechanisms of action of atypical antipsychotic drugs. Implication for novel therapeutic strategies for schizophrenia. Schizophr. Res. 4, 121-156.
10. Di Giovanni G., De Deurwaerdère P., Di Mascio M., Di Matteo V., Esposito E., and Spampinato U. (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91, 587-597.
11. Dray A. (1981) Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. J. Physiol. (Paris) 77, 393-403.
12. Dray A., Gonye T. J., Oakley N. R., and Tanner T. (1976) Evidence for the existence of a raphe projection to the substantia nigra. Brain Res. 113, 45-57.
13. 2B receptor protein in the rat central nervous system. Neuroscience 76, 323-329.
14. 2 agonists. Eur. J. Pharmacol. 264, 325-330.
15. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R., and Humphrey P. P (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
16. Huang X. and Nichols D. E. (1993) 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. Eur. J. Pharmacol. 238, 291-296.
17. Ichikawa J. and Meltzer H. Y. (1992) Amperozide, a novel antipsychotic drug, inhibits the ability of D-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens. J. Neurochem. 58, 2285-2291.
18. Ichikawa J. and Meltzer H. Y. (1995) DOI, a 5-HT2A/2C agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res. 698, 204-208.
19. James T. A. and Starr M. S. (1980) Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. J. Pharm. Pharmacol. 32, 196-200.
20. Kapur S. and Remington G. (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 153, 466-476.
21. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117, 427-434.
22. Kurata K. and Shibata R. (1991) Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis. Pharmacology 42, 1-9.
23. 2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: a combined dialysis and electrophysiological analysis. Soc. Neurosci. Abstr. 23, 975.
24. 2 antagonist. Mol. Pharmacol. 27, 600-611.
25. 2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology (Berl.) 131, 57-63.
26. 2 receptors in the dorsal raphe nucleus increases firing rate and 5-HT release in the rat brain. Soc. Neurosci. Abstr. 23, 2328.
27. Meltzer H. Y. and Nash J. F. (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol. Rev. 43, 587-604.
28. Mendlin A., Martin F. J., and Jacobs B. L. (1998) Involvement of dopamine D2 receptors in apomorphine-induced facilitation of forebrain serotonin output. Eur. J. Pharmacol. 351, 291-298.
29. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., and Palacios J. M. (1990) The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35, 577-591.
30. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37, 953-955.
31. Monsma F. J., Shen Y., Ward R. P., Hamblin M. W., and Sibley D. R. (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43, 320-327.
32. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, Orlando.
33. Pazos A., Cortés R., and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231-249.
34. 2C receptors. Mol. Brain Res. 23, 163-178.
35. Rinaldi-Carmona M., Congy C., Santucci V., Simiand V., Gautret B., Neliat G., Labeeuw B., Le Fur G., Soubrie P., and Breliere J. C. (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J. Pharmacol. Exp. Ther. 262, 759-768.
36. 2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 223, 65-74.
37. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J. Neurochem. 62, 1382-1389.
38. Schotte A., Janssen P. F. M., Megens A. A. H. P., and Leysen J. E. (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 631, 191-202.
39. 2C receptors. Pharmacol. Biochem. Behav. 61, 323-330.
40. Soubrié P., Reisine T. D., and Glowinski J. (1984) Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience 13, 605-625.
41. 2C receptor subtypes in the control of haloperidol-induced release of dopamine in the rat striatum. Soc. Neurosci. Abstr. 24, 108.
42. Spoont M. R. (1992) Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol. Bull. 112, 330-350.
43. 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 48, 200-205.
44. Wright D. E., Seroogy K. B., Lundgren K. H., Davis B. M., and Jennes L. (1995) Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351, 357-373.
45. Wurtman R. J. and Balcioglu A. (1998) DOI, a 5-HT2 receptor agonist, increases both DA and 5-HT release in rat striatum. Soc. Neurosci. Abstr. 24, 1370.
46. Yamamoto B. K., Nash J. F., and Gudelsky G. A. (1995) Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and γ-aminobutyric acid in the substantia nigra. J. Pharmacol. Exp. Ther. 273, 1063-1070.
47. Zetterström T., Sharp T., and Ungerstedt U. (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur. J. Pharmacol. 132, 1-9.
48. Zetterström T., Sharp T., Collin A. K., and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327-334.